Antiosteoporosis effect of bryodulcosigenin on ovariectomy-induced osteoporosis in experimental rats
CONCLUSIONS: Bryodulcosigenin reduced the cytokines level and suppressed the TGF-β and IGF. We concluded that bryodulcosigenin is an antiosteoporosis medication based on the findings.PMID:38656061 | PMC:PMC11037890 | DOI:10.1590/acb391024
Source: Acta Cirurgica Brasileira - Category: Surgery Authors: Kai Sun Lin Qin Source Type: research
More News: Alternative and Complementary Therapies | Antidoxidants | Complementary Medicine | Hormones | Insulin | Orthopaedics | Osteoporosis | Study | Surgery | Switzerland Health | Women